Global Prostate Cancer Therapeutics Market and Investment Analysis Report 2017-2023

According to Stratistics MRC, the Global Prostate Cancer Therapeutics market is estimated at $XX million in 2016 and is expected to reach $XX million by 2023 growing at a CAGR of XX% from 2016 to 2023. Increase in prostate cancer cases in recent years and raise in development of innovative drugs are the some of the prominent factors driving the market growth. Whereas high cost and low success rate in the clinical test are hampering the market. However, increase in geriatric population and increase in R&D expenditure in this market seems to be opportunity for the market growth. In 2016, North America accounted for the highest market share owing to increase in research and development expenditure. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of government initiatives on creating awareness on prostate cancer.

Browse the report: http://www.orbisresearch.com/reports/index/prostate-cancer-therapeutics-global-market-outlook-2017-2023

Some of the key players in the market include Tolmar Inc, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, Ipsen, Ferring Pharmaceuticals, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc), Dendreon Corporation, Bristol-Myers Squibb, Astrazeneca Plc, Astellas Pharma Inc, Active Biotech and Abbott Laboratories.

Drugs Classes Covered:
Chemotherapy
Estramustine (Emcyt)
Mitoxantrone (Novantrone)
Jevtana
Taxotere
Targeted Therapy
Xofigo
Hormonal Therapy
Anti-Androgens
Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
Immunotherapy
Provenge

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/353478

Distribution Channels Covered:
Hospital Pharmacy
Retail Pharmacy
Online Sales
Other Distribution Channels

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

List Of Tables:

1 Global Prostate Cancer Therapeutics Market Outlook, By Region

2 Global Prostate Cancer Therapeutics Market Outlook, By Drugs Class

3 Global Prostate Cancer Therapeutics Market Outlook, By Chemotherapy

4 Global Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt)

5 Global Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone)

6 Global Prostate Cancer Therapeutics Market Outlook, By Jevtana

7 Global Prostate Cancer Therapeutics Market Outlook, By Taxotere

8 Global Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy

9 Global Prostate Cancer Therapeutics Market Outlook, By Xofigo

10 Global Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy

11 Global Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens

12 Global Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists

13 Global Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs

14 Global Prostate Cancer Therapeutics Market Outlook, By Immunotherapy

15 Global Prostate Cancer Therapeutics Market Outlook, By Provenge

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.